HTA in Europe: Fair Value or False Economy?

Download your free HEOR Roadmap here: https://mirkovonhein.com/roadmap Get my free weekly HEOR newsletter: https://pharmaradar.beehiiv.com/ Want to master HEOR? Enrol in my structured training: https://mirkovonhein.com/course ---------------------------------------- VIDEO SUMMARY 🎬 This video explores the US pharmaceutical pricing dominance, European drug reimbursement policies, and the future of NICE willingness-to-pay thresholds in healthcare innovation funding. 💊📉🏛️ Want to understand how you can compare different Health Technology Assessments Systems? Watch this 👉 https://www.youtube.com/watch?v=gSrGK0FW7CM&list=UULFCWndUzziarMjA4pDG1ps2A&t=1s ---------------------------------------- CONNECT WITH ME 📲 Discord: https://discord.com/invite/BpbnpFXxnm Twitter: https://x.com/vonHeinMirko LinkedIn: https://www.linkedin.com/in/mirko-von-hein-b9885110b/ Instagram: https://www.instagram.com/mirkovonhein Facebook: https://www.facebook.com/profile.php?id=61566466527249 Website: https://mirkovonhein.com/ ---------------------------------------- PHARMA GLOSSARY 🔍 A free tool to decode industry terms, abbreviations, and acronyms in pharma. Explore it here: https://mirkovonhein.com/pharma-glossary/ ---------------------------------------- TIMECODES ⏰ 0:00 Intro 0:09 About the Speaker: My Motivation 1:43 Legal Disclaimer 1:59 Agenda: 3 Things to Talk About 3:20 How Much Drug Revenue is Generated in the US? 3:53 Contextualising the High US Drug Market Share 5:15 What if Pharma Can’t Rely on the US Anymore to Fund Global Innovation? 8:34 The Relationship between Market Size and Innovation 9:24 How does GDP per capita Affect Health Spending? 10:50 Does Spending More Money on Health Equal Better Health Outcomes? 12:09 Why is the US Healthcare System so Inefficient? 13:23 Does the US Pay More for Prescription Drugs? 15:02 The Generic Drug Armamentarium (Peter Kolchinsky) 15:54 The Drug Lifecycle: Why High Prices Today Enable Cheap Generics Tomorrow 17:20 What is Most Favoured Nation (MFN) Pricing? 18:27 The UK Response to Pressure from the US: Will We See an Increase in the WTP? 19:49 The NICE Willingness-to-Pay Threshold has Declined in Real Terms 20:57 Will a Higher WTP Solve the Problem? 22:08 Pharma Clawback Rates in Europe: A Comparison 23:00 VPAG Growth Rate VS. Healthcare Budget Growth Rate 23:46 How Many New Drugs Should Receive Reimbursement? 24:41 Should We STOP Reimbursing New Drugs? 27:31 What does it Cost the NHS to Produce 1 QALY? 29:14 Foreign Investment in Major Marks & Competitiveness Rankings 30:12 Audience Poll: How Many Drugs Should We Say YES to? 33:03 How NICE Appraisals Should Work and How They Feel in Practice 35:49 Is the NICE Appraisal Process Fair and Objective? 36:48 Are We Focusing on the Right Thing? Healthcare Expenditure Breakdown 37:11 Hospital Costs as the Largest Healthcare Cost Driver 37:49 Time to Access for New Drugs in the EU 37:55 Do HTA Bodies in Different Countries Come to the same Conclusions? 38:31 What Drug Price Control Mechanisms are in Place in Europe? 38:58 The Three Pillars of Fair Value in Healthcare 41:59 What Should Healthcare Systems Optimise for? 44:06 References 44:13 Outro ---------------------------------------- SUBSCRIBE TO MY CHANNEL 🔔 https://www.youtube.com/@MirkovonHein?sub_confirmation=1 ---------------------------------------- REFERENCES 📚 Full List of References in Slides (Download Link below) ---------------------------------------- TEMPLATES 🗂️ Download the Slides for this presentation here: Add Link ---------------------------------------- HASHTAGS 🏷️ #PharmaceuticalPricing #EuropeanHealthcare #HealthEconomics